Literature DB >> 22514375

An improved immunofluorescent reagent for rapid, direct detection of Bordetella pertussis.

D Martin1, P McNicol, R Marchand, P Lebel, M S Peppler, B R Brodeur.   

Abstract

Year:  1995        PMID： 22514375      PMCID： PMC3327899          DOI： 10.1155/1995/915203

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN： 1180-2332


× No keyword cloud information.
  12 in total

1.  Immunological characterization of the lipooligosaccharide B band of Bordetella pertussis.

Authors:  D Martin; M S Peppler; B R Brodeur
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

2.  Pertussis: the trials and tribulations of old and new pertussis vaccines.

Authors:  J D Cherry
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

3.  Major outbreak of pertussis in northern Alberta, Canada: analysis of discrepant direct fluorescent-antibody and culture results by using polymerase chain reaction methodology.

Authors:  C A Ewanowich; L W Chui; M G Paranchych; M S Peppler; R G Marusyk; W L Albritton
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

Review 4.  Biology of Bordetella bronchiseptica.

Authors:  R A Goodnow
Journal:  Microbiol Rev       Date:  1980-12

5.  Characterization and comparative bactericidal activity of monoclonal antibodies to Bordetella pertussis lipo-oligosaccharide A.

Authors:  D Archambault; P Rondeau; D Martin; B R Brodeur
Journal:  J Gen Microbiol       Date:  1991-04

6.  Erythromycin-resistant Bordetella pertussis--Yuma County, Arizona, May-October 1994.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1994-11-11       Impact factor: 17.586

7.  Analysis of protective and nonprotective monoclonal antibodies specific for Bordetella pertussis lipooligosaccharide.

Authors:  R D Shahin; J Hamel; M F Leef; B R Brodeur
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

Review 8.  Epidemiology of pertussis and reactions to pertussis vaccine.

Authors:  S L Hodder; E A Mortimer
Journal:  Epidemiol Rev       Date:  1992       Impact factor: 6.222

9.  Clinical impact of rapid in vitro susceptibility testing and bacterial identification.

Authors:  G V Doern; R Vautour; M Gaudet; B Levy
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

10.  Prevention of secondary transmission of pertussis in households with early use of erythromycin.

Authors:  M A Sprauer; S L Cochi; E R Zell; R W Sutter; J R Mullen; S J Englender; P A Patriarca
Journal:  Am J Dis Child       Date:  1992-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.